PatternsRadar
Sign in

SUNPHARMASun Pharmaceutical Industries Limited

NSEF&O
1,884.90INR-15.10 (-0.79%)Close · 20 Nov 2026
30 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹4.52L CrMarket cap
41.2P/E (TTM)
57.5%Delivery

Filings & corporate actions

86 results filed
CSV
Next results · Q3 FY27
Expected 31 Jan 2027 – 31 Jan 2027
Estimate: filed 31–31 days after quarter end, last 5 times
Dividend
₹5.00 per share · last 7 Jul 2026
2026
  • 30 OctresultsResults · Q2 FY27 · consolidated and standalone-0.4%NSE
  • 15 OctshareholdingShareholding · 30 Sept 2026+1.0%NSE
  • 31 JulresultsResults · Q1 FY27 · consolidated and standalone-1.4%NSE
  • 17 JulshareholdingShareholding · 30 Jun 2026-0.9%NSE
  • 7 JuldividendDividend · ₹5.00 per share-0.5%
  • 22 MayresultsResults · Q4 FY26 · consolidated and standalone-0.2%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026-1.0%NSE
  • 5 FebdividendDividend · ₹11.00 per share-0.1%
  • 31 JanresultsResults · Q3 FY26 · consolidated and standalone+0.9%NSE
  • 15 JanshareholdingShareholding · 31 Dec 2025-1.9%NSE

Reaction to results · all yearsrose on day 0 in 39 of 77 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2730 Oct 2026-0.4%+7.7%—2.1×
Q1 FY2731 Jul 2026-1.4%-2.3%-0.3%1.6×
Q4 FY2622 May 2026-0.2%-3.0%+1.3%0.6×
Q3 FY2631 Jan 2026+0.9%+6.3%+8.9%0.9×
Q2 FY265 Nov 2025-0.2%+2.8%+7.6%1.9×
Q1 FY2631 Jul 2025-4.5%-7.0%-8.3%4.9×
Q4 FY2522 May 2025-2.0%-2.4%-3.1%2.9×
Q3 FY2531 Jan 2025-0.1%+0.3%-9.1%0.8×
Q2 FY2528 Oct 2024-1.6%-5.2%-8.9%1.3×
Q1 FY251 Aug 2024+1.0%+1.2%+5.9%1.3×
Q4 FY2422 May 2024-2.9%-5.2%-4.7%5.7×
Q3 FY2431 Jan 2024-0.7%+5.7%+11.2%1.1×
Q2 FY241 Nov 2023+1.5%+5.4%+10.3%1.9×
Q1 FY243 Aug 2023-0.2%-0.8%-2.8%1.2×
Q4 FY2326 May 2023-0.1%+4.0%+2.6%2.1×
Q3 FY2331 Jan 2023-1.9%-2.1%-7.3%2.2×
Q2 FY231 Nov 2022+1.5%-2.5%+1.0%2.1×
Q1 FY2329 Jul 2022-2.6%-3.5%-7.6%1.5×
Q4 FY2231 May 2022-3.1%-4.5%-6.7%7.5×
Q3 FY2231 Jan 2022+6.9%+7.1%-1.6%3.3×
Q2 FY222 Nov 2021-3.4%-2.5%-7.8%2.7×
Q1 FY2230 Jul 2021+0.1%+1.9%+2.6%3.8×
Q4 FY2128 May 2021-4.3%-3.7%-3.9%3.5×
Q3 FY2129 Jan 2021+0.7%+8.3%+3.1%1.6×
Q2 FY214 Nov 2020+3.9%+4.2%+17.2%5.9×
Q1 FY211 Aug 2020-2.3%+2.3%-2.2%2.3×
Q4 FY2027 May 2020+1.8%+9.7%+8.2%1.1×
Q3 FY206 Feb 20200.0%-2.8%-8.7%1.9×
Q2 FY208 Nov 2019-4.2%-3.6%-3.1%2.2×
Q1 FY2013 Aug 2019-5.0%-5.6%-2.8%2.6×
Q4 FY1929 May 2019+2.7%-2.1%-2.4%3.7×
Q3 FY1920 Feb 2019+1.7%+5.4%+10.0%0.5×
Q2 FY1922 Nov 2018-2.9%-13.4%-19.3%0.9×
Q1 FY1931 Aug 2018+2.0%+3.8%-3.0%1.6×
Q4 FY1819 Jun 2018+0.7%+3.0%-1.8%0.5×
Q3 FY1822 Feb 2018+5.2%+1.3%-7.1%4.0×
Q2 FY1821 Nov 2017+4.0%+5.0%+2.0%1.6×
Q1 FY1821 Aug 2017+2.1%+5.1%+9.8%0.7×
Q4 FY1718 Jun 2017-0.8%+2.8%+9.3%0.4×
Q3 FY1717 Feb 2017+4.0%+3.9%+7.5%1.7×
Q2 FY1710 Nov 2016+3.3%+3.6%+1.5%3.0×
Q1 FY1721 Sept 2016+1.0%-5.5%-4.1%0.7×
Q4 FY1631 May 2016-6.1%-9.0%-5.8%5.9×
Q3 FY1613 Feb 2016+0.3%+4.1%-0.5%1.2×
Q2 FY167 Nov 2015-5.8%-6.2%-5.5%3.6×
Q1 FY1611 Aug 2015+2.9%+10.2%-0.3%1.2×
Q4 FY154 Jun 2015-1.3%-2.7%+3.4%1.4×
Q3 FY1518 Feb 2015-0.1%-5.7%+14.2%0.5×
Q2 FY1519 Nov 2014-1.9%-3.1%-6.4%1.7×
Q1 FY1518 Aug 2014+0.2%+4.7%-2.0%0.7×
Q4 FY1429 May 2014+4.1%+2.2%+12.7%4.3×
Q3 FY1419 Feb 2014-0.6%+3.4%-6.2%0.6×
Q2 FY1421 Nov 2013-1.1%-1.6%-0.4%1.5×
Q1 FY1414 Aug 2013+0.6%-8.3%+3.0%0.7×
Q4 FY136 Jun 2013-1.8%-8.4%-0.6%0.6×
Q3 FY138 Feb 2013+0.4%+5.6%+11.7%1.0×
Q2 FY138 Nov 2012-0.3%-2.3%+2.7%0.7×
Q1 FY1310 Aug 2012+1.0%-1.7%+1.4%1.1×
Q4 FY121 Jun 2012+0.4%+2.9%+12.1%0.9×
Q3 FY1213 Feb 2012+2.2%+0.3%+7.8%2.3×
Q2 FY1214 Nov 2011+1.3%-1.1%+1.6%1.3×
Q1 FY1228 Jul 2011-0.2%-3.9%-10.3%1.1×
Q4 FY1130 May 2011+4.4%+7.4%+10.5%2.6×
Q3 FY1131 Jan 2011-1.8%-8.6%-5.6%1.5×
Q2 FY1130 Oct 2010+3.8%+8.8%+6.1%1.5×
Q1 FY1128 Jul 2010+1.8%+0.2%+0.7%2.7×
Q3 FY1029 Jan 2010+2.3%+0.7%+5.3%1.5×
Q2 FY1028 Oct 2009+0.5%+1.1%+7.0%1.4×
Q1 FY1029 Jul 2009-5.4%-5.9%-3.9%2.7×
Q3 FY0930 Jan 2009-2.6%+1.6%-9.6%1.1×
Q2 FY0925 Oct 2008-8.0%-17.5%-13.7%1.1×
Q1 FY0928 Jul 2008+1.1%+4.1%+6.1%0.8×
Q4 FY0830 May 2008+3.1%+3.8%-0.1%1.5×
Q3 FY0830 Jan 2008+8.7%+3.2%+13.0%2.8×
Q2 FY0825 Oct 2007+2.5%+5.5%+8.4%0.6×
Q1 FY0823 Jul 2007+0.8%-5.5%-3.6%2.2×
Q4 FY0718 May 2007-0.3%+4.8%+4.0%0.3×
Average+0.1%+0.1%+0.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+11.9%
Profit YoY-36.2%
Interest cost YoY+23.0%
Revenue QoQ+5.9%
Profit QoQ-31.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue—+10.0%+10.7%+10.9%+11.3%+10.1%
Profit—+8.7%+27.8%+11.9%+39.8%+14.2%

Key data

Open1,898.00
Day range1,883.00 – 1,910.00
52-week range1,583.70 – 2,046.90
From 52w high-7.9%
RSI (14)61.3
ATR (14)40.25
Volume19.16L
Avg volume (20D)23.48L
Rel volume0.82×
Volatility (1Y)19.7%
Turnover₹362.5Cr
Traded value (NSE)₹362.5Cr
VWAP1,892.13
SMA 50 / 2001,818.22 / 1,823.19
Price bandNo band
MWPL used19.2%

Delivery percentage

Latest · 20 Nov 202657.5%
20-day avg56.1%
1-year avg63.7%
Percentile (own history)54th
Range8.1–90.2%
Sessions3,629

Over the last 20 sessions SUNPHARMA settled 56.1% of its traded quantity, which is above average for an NSE equity. Its one-year average is 63.7%, so recent sessions are running 7.6 points lower than usual. The latest session ranks higher than 54% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.85%
Dividend, trailing 12M₹16.00
Paid every year for10+ yr
Shareholders7.14L · +0.6% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy4,231 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.79%+0.26%+7.22%-1.00%-0.34%+7.27%

Valuation

Market cap₹4.52L Cr
Market cap (NSE)₹4.52L Cr
Free-float cap₹2.14L Cr
P/E (TTM)41.2
P/E (NSE)41.5
EPS (TTM)45.70
P/B5.1
Net margin (TTM)17.8%
Other income / PBT15.2%
ROE13.1%
Debt / equity0.03
Shares outstanding239.93Cr
Listed8 Feb 1995

Ownership

Promoter52.68%
Promoter Δ QoQ-1.80 pp
Public47.32%
FII14.36%
DII22.27%
Pledged0.01%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)15,520.514,611.815,299.916,198.7
YoY chg+13.5%+12.8%+10.5%+11.9%
Net profit (₹ Cr)3,381.22,709.72,901.21,995.1
YoY chg+16.1%+25.8%+26.5%-36.2%
Net margin21.8%18.5%19.0%12.3%
EPS14.0011.3012.108.30

Shareholding over time

By quarter

30 Sept 2026 · promoter 52.68% · public 47.32%
30 Sept 2021: promoter 54.48%31 Dec 2021: promoter 54.48%31 Mar 2022: promoter 54.48%30 Jun 2022: promoter 54.48%30 Sept 2022: promoter 54.48%31 Dec 2022: promoter 54.48%31 Mar 2023: promoter 54.48%30 Jun 2023: promoter 54.48%30 Sept 2023: promoter 54.48%31 Dec 2023: promoter 54.48%31 Mar 2024: promoter 54.48%30 Jun 2024: promoter 54.48%30 Sept 2024: promoter 54.48%31 Dec 2024: promoter 54.48%31 Mar 2025: promoter 54.48%30 Jun 2025: promoter 54.48%30 Sept 2025: promoter 54.48%31 Dec 2025: promoter 54.48%31 Mar 2026: promoter 54.48%30 Jun 2026: promoter 54.48%30 Sept 2026: promoter 52.68%
2021-092026-09
  • Promoter
  • Public and others
Promoter
52.68%
Public
47.32%
Promoter change
-1.80 pp
Filed
15 Oct 2026
FII
14.36%
DII
22.27%
Promoter pledged
0.01%

Who the public is

Mutual funds
13.01%

+0.17 pp QoQ

Insurance
6.80%

-0.22 pp QoQ

FPI
14.36%

-0.18 pp QoQ

Retail ≤ ₹2L
4.39%

+0.01 pp QoQ

HNI > ₹2L
2.32%

+1.22 pp QoQ

NRI
0.29%

0.00 pp QoQ

Bodies corporate
2.32%

+0.27 pp QoQ

Shareholders
7,14,266

+0.6% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Shanghvi Finance Private LimitedPromoter · Corporate40.30%
Dilip.S.ShanghviPromoter · Individual9.60%
Life Insurance Corporation Of IndiaInsurance5.32%
Icici Prudential Value FundMutual fund3.21%
Sbi Nifty 50 EtfMutual fund2.82%
Nps Trust- A/C Hdfc Pension Fund Management Limited Scheme E - Tier IPension / PF1.96%
Aditya Medisales LimitedPromoter · Corporate1.67%
Nippon Life India Trustee Ltd-A/C Nippon India Etf Nifty 50 BeesMutual fund1.32%
Raksha Sudhir ValiaIndividual1.20%
Hdfc Trustee Company Ltd. A/C Hdfc Balanced Advantage FundMutual fund1.14%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 14 Aug 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹5.00₹5.00
FY2025-262₹16.50₹16.50
FY2024-252₹15.50₹15.50
FY2023-242₹12.50₹12.50
FY2022-232₹10.50₹10.50
FY2021-222₹9.00₹9.00
FY2020-212₹6.50₹6.50
FY2019-202₹5.75₹5.75
FY2018-191₹2.00₹2.00
FY2017-181₹3.50₹3.50
FY2016-171₹1.00₹1.00
FY2015-161₹3.00₹3.00
FY2014-151₹1.50₹1.50
FY2013-141₹2.50₹2.50
FY2012-131₹4.25₹2.13
Ex-dateRecord dateDeclaredAdjusted
7 Jul 2026—₹5.00₹5.00
5 Feb 2026—₹11.00₹11.00
7 Jul 2025—₹5.50₹5.50
6 Feb 2025—₹10.50₹10.50
12 Jul 2024—₹5.00₹5.00
9 Feb 2024—₹8.50₹8.50
28 Jul 2023—₹4.00₹4.00
8 Feb 2023—₹7.50₹7.50
19 Aug 2022—₹3.00₹3.00
9 Feb 2022—₹7.00₹7.00
23 Aug 2021—₹2.00₹2.00
9 Feb 2021—₹5.50₹5.50
19 Aug 2020—₹1.00₹1.00
17 Feb 2020—₹3.00₹3.00
20 Aug 2019—₹2.75₹2.75
17 Sept 2018—₹2.00₹2.00
18 Sept 2017—₹3.50₹3.50
8 Sept 2016—₹1.00₹1.00
21 Oct 2015—₹3.00₹3.00
11 Sept 2014—₹1.50₹1.50
19 Sept 2013—₹2.50₹2.50
14 Aug 2012—₹4.25₹2.13

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
6.7 years ago
Disclosures on record
1,084
40 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
20 Mar 2023Sailesh T. DesaiDirectorSell4.0K₹38.6L965.7419.97L → 19.93L0.10%-0.00 pp7(2)told 17 Mar 2023
23 Dec 2022Sailesh T. DesaiDirectorSell5.0K₹51.4L1,028.1420.06L → 20.01L0.10%-0.00 pp7(2)told 23 Dec 2022
23 Dec 2022Sailesh T. DesaiDirectorSell2.0K₹20.4L1,021.5919.99L → 19.97L0.10%-0.00 pp7(2)told 23 Dec 2022
23 Dec 2022Sailesh T. DesaiDirectorSell2.0K₹20.5L1,025.0020.01L → 19.99L0.10%-0.00 pp7(2)told 23 Dec 2022
8 Dec 2022Nilesh GandhiEmployeeSell2.0K₹20.6L1,028.546.0K → 4.0K0.00%0.00 pp7(2)told 7 Dec 2022
8 Dec 2022PRITI GANDHIRelativeSell3.0K₹30.9L1,030.0029.2K → 26.2K0.00%0.00 pp7(2)told 7 Dec 2022
2 Dec 2022Desai Associates (Partnership firm in which Meera Desai, wife of Sailesh T. Desai, WTD is a PartnerOtherSell1.0K₹10.6L1,055.001.59L → 1.58L0.01%-0.00 pp7(2)told 1 Dec 2022
1 Dec 2022Desai Associates (Partnership firm in which Meera Desai, wife of Sailesh T. Desai, WTD is a PartnerOtherSell1.0K₹10.5L1,049.001.60L → 1.59L0.01%-0.00 pp7(2)told 30 Nov 2022
1 Dec 2022Sailesh T. DesaiDirectorSell6.0K₹62.9L1,047.6320.12L → 20.06L0.09%-0.00 pp7(2)told 30 Nov 2022
25 Nov 2022Sailesh T. DesaiDirectorSell10.0K₹1.0Cr1,030.4520.22L → 20.12L0.09%-0.00 pp7(2)told 25 Nov 2022
4 Oct 2022Julie R ShahRelativeSell1.5K₹14.1L940.971.70L → 1.68L0.00%0.00 pp7(2)told 4 Oct 2022
3 Oct 2022Julie R ShahRelativeSell1.4K₹13.0L926.281.71L → 1.70L0.00%0.00 pp7(2)told 30 Sept 2022
3 Oct 2022Sailesh T. DesaiDirectorSell9.0K₹85.2L946.3420.81L → 20.72L0.09%-0.00 pp7(2)told 30 Sept 2022
3 Oct 2022Sailesh T. DesaiDirectorSell25.0K₹2.4Cr941.6021.06L → 20.81L0.09%-0.00 pp7(2)told 30 Sept 2022
29 Sept 2022Sailesh T. DesaiDirectorSell14.0K₹1.3Cr915.3521.20L → 21.06L0.10%-0.00 pp7(2)told 29 Sept 2022
29 Sept 2022Sailesh T. DesaiDirectorSell2.0K₹18.5L924.0021.22L → 21.20L0.10%-0.00 pp7(2)told 29 Sept 2022
23 Sept 2022Sailesh T. DesaiDirectorSell12.0K₹1.1Cr917.5021.34L → 21.22L0.10%-0.00 pp7(2)told 23 Sept 2022
23 Sept 2022Sailesh T. DesaiDirectorSell10.0K₹90.8L908.0621.44L → 21.34L0.10%-0.00 pp7(2)told 23 Sept 2022
22 Sept 2022Sailesh T. DesaiDirectorSell15.0K₹1.4Cr912.5821.59L → 21.44L0.10%-0.00 pp7(2)told 22 Sept 2022
1 Apr 2022Sailesh T. DesaiDirectorSell2.0K₹18.5L925.0021.61L → 21.59L0.10%-0.00 pp7(2)told 31 Mar 2022
21 Mar 2022Sailesh T. DesaiDirectorSell15.4K₹1.4Cr908.7321.89L → 21.73L0.10%-0.00 pp7(2)told 17 Mar 2022
4 Jan 2022Julie R ShahRelativeSell2.0K₹16.9L843.661.63L → 1.61L0.00%0.00 pp7(2)told 3 Jan 2022
3 Jan 2022Sailesh T. DesaiDirectorSell7.0K₹59.3L847.5623.96L → 23.89L0.10%-0.00 pp7(2)told 31 Dec 2021
3 Jan 2022Desai AssociatesOtherSell6.0K₹50.9L848.001.66L → 1.60L0.01%-0.00 pp7(2)told 31 Dec 2021
3 Jan 2022Desai AssociatesOtherSell10.0K₹83.3L832.701.76L → 1.66L0.01%-0.00 pp7(2)told 30 Dec 2021
3 Jan 2022Sailesh T. DesaiDirectorSell17.0K₹1.4Cr832.9424.13L → 23.96L0.10%-0.00 pp7(2)told 30 Dec 2021
3 Jan 2022Julie R ShahRelativeSell3.0K₹24.7L822.451.66L → 1.63L0.00%0.00 pp7(2)told 30 Dec 2021
28 Dec 2021Sailesh T. DesaiDirectorSell13.0K₹1.1Cr808.7724.26L → 24.13L0.10%-0.00 pp7(2)told 28 Dec 2021
28 Dec 2021Desai AssociatesOtherSell16.0K₹1.3Cr807.721.92L → 1.76L0.01%-0.00 pp7(2)told 28 Dec 2021
28 Dec 2021Desai AssociatesOtherSell3.0K₹23.8L793.361.95L → 1.92L0.01%-0.00 pp7(2)told 28 Dec 2021
27 Dec 2021Sailesh T. DesaiDirectorSell5.0K₹40.0L799.0024.31L → 24.26L0.10%-0.00 pp7(2)told 23 Dec 2021
27 Dec 2021Desai AssociatesOtherSell10.0K₹79.4L793.602.05L → 1.95L0.01%-0.00 pp7(2)told 23 Dec 2021
22 Dec 2021Desai AssociatesOtherSell2.0K₹15.4L771.002.11L → 2.09L0.01%-0.00 pp7(2)told 21 Dec 2021
22 Dec 2021Desai AssociatesOtherSell4.0K₹31.2L780.692.09L → 2.05L0.01%-0.00 pp7(2)told 21 Dec 2021
17 Dec 2021Desai AssociatesOtherSell2.0K₹15.5L774.802.13L → 2.11L0.01%-0.00 pp7(2)told 17 Dec 2021
15 Dec 2021Desai AssociatesOtherSell131₹1.0L767.152.13L → 2.13L0.01%-0.00 pp7(2)told 13 Dec 2021
13 Dec 2021Desai AssociatesOtherSell2.0K₹15.3L766.502.15L → 2.13L0.01%-0.00 pp7(2)told 10 Dec 2021
13 Dec 2021Desai AssociatesOtherSell1.0K₹7.7L765.002.16L → 2.15L0.01%-0.00 pp7(2)told 10 Dec 2021
6 Dec 2021Desai AssociatesOtherSell5.0K₹38.2L764.162.21L → 2.16L0.01%-0.00 pp7(2)told 3 Dec 2021
4 Oct 2021Subhas BhowmickOtherSell10.0K₹82.1L820.8958.3K → 48.3K0.00%0.00 pp7(2)told 4 Oct 2021

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 24 Jun 2026

CSV
12 of 53 deals
By year
DateDealClientQuantityPriceValue
24 Jun 2026Sell · blockTHE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ4000458281.54L1,868.00₹28.8Cr
24 Jun 2026Buy · blockTHE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB4000457941.54L1,868.00₹28.8Cr
18 Nov 2025Buy · blockGQG PARTNERS EMERGING MARKETS EQUITY CIT14.46L1,763.90₹255.1Cr
18 Nov 2025Sell · blockRELIANCE TRUST INSTITUTIONAL RETIREMENT TRUST SERIES TWELVE14.46L1,763.90₹255.1Cr
9 Oct 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE - ODI1.48L1,631.60₹24.2Cr
9 Oct 2025Buy · blockGOLDMAN SACHS BANK EUROPE SE - ODI1.48L1,631.60₹24.2Cr
14 Jul 2025Sell · blockTHE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ4000458283.09L1,672.00₹51.7Cr
14 Jul 2025Buy · blockTHE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ4000458493.09L1,672.00₹51.7Cr
25 Jan 2024Sell · blockSOCIETE GENERALE1.31L1,382.10₹18.1Cr
25 Jan 2024Buy · blockMARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND1.28L1,382.10₹17.7Cr
25 Jan 2024Buy · blockMARSHALL WACE INVESTMENT STRATEGIES TOPS FUND3.2K1,382.10₹43.7L
25 Jan 2024Buy · blockMARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND261,382.10₹35,935

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to SUNPHARMA.

Price band: No band · not in the F&O ban · 19.2% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes · MWPL.

Every stock on this session →

Futures & options · 20 Nov 2026

CSV

Long unwinding — price down as positions closed — longs exiting.

Futures OI
2.20Cr

₹4,155.3Cr

OI change
-2.37%
Basis
0.00%
Rollover
80.2%
PCR (OI)
0.70
PCR (volume)
0.64
Front settle
1,884.90
Lot size
350

shares

Futures volume
26.4K

contracts

Futures trades
21,160
Futures value
₹1,750.5Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Option chain · 20 Nov 2026 · lot 350

Put OICall OI
Max pain
1,820

-3.4% from spot

Call OI wall
1,960
Put OI wall
1,700
PCR (OI, this expiry)
0.67
PutsStrikeCalls
1,640
1,660
1,680
1,700PW
1,720
1,740
1,760
1,780
1,800
1,820MP
1,840
1,860
1,880
Spot 1,884.9
1,900
1,920
1,940
1,960CW
1,980
2,000
2,020
2,040
2,060
2,080
2,100
2,120

1,820: puts 3.93L OI (−39.9K), close 0.15, ₹33.2Cr notional in 457 trades · calls 5.92L OI (−7.0K), close 63.05, ₹17.4Cr notional in 256 trades

Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.

Financials · quarterly statement

₹ crore, as filed
By year
 Q2 FY24Q3 FY24Q4 FY24AQ2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations12,192.412,380.711,982.913,291.413,675.512,958.813,851.414,478.315,520.514,611.815,299.916,198.7
Other income293.6250.2605.9354.0465.6612.9464.5469.9578.8458.5723.6517.3
Total income12,486.012,630.912,588.813,645.414,141.113,571.714,315.914,948.216,099.415,070.316,023.516,716.0
Total expenses9,695.19,560.79,671.710,047.510,348.59,955.710,325.110,780.611,382.711,519.011,720.612,287.8
└ Finance costs49.334.773.669.251.549.174.899.978.485.999.774.7
└ Depreciation632.8622.1650.4625.9630.6663.8700.6729.5732.3775.5738.7758.3
Profit before tax2,790.93,000.42,815.53,597.93,476.43,254.43,172.84,167.64,227.23,551.34,098.83,159.4
Tax expense390.1432.3148.9567.2558.91,093.7870.21,030.5826.1827.61,188.01,157.8
Net profit2,385.12,560.52,658.73,037.32,913.02,153.92,292.93,125.03,381.22,709.72,901.21,995.1
EPS9.9010.5011.1012.7012.109.009.5013.0014.0011.3012.108.30
Net margin19.56%20.68%22.19%22.85%21.30%16.62%16.55%21.58%21.79%18.54%18.96%12.32%
PBT margin22.89%24.23%23.50%27.07%25.42%25.11%22.91%28.79%27.24%24.30%26.79%19.50%
Tax rate13.98%14.41%5.29%15.77%16.08%33.61%27.43%24.73%19.54%23.30%28.98%36.65%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 30 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets80,743.679,441.285,462.988,115.792,100.61,03,706.51,08,785.21,14,838.4
Current assets39,861.939,332.743,433.146,068.952,594.160,136.463,860.369,266.6
└ Cash & equivalents4,623.75,403.19,285.78,012.510,268.810,022.49,770.518,401.0
└ Other bank balances1,146.61,818.91,235.01,002.51,062.92,235.11,832.61,967.4
└ Current investments9,372.67,611.28,584.511,107.213,656.115,623.020,933.513,201.8
└ Trade receivables11,438.511,302.711,249.412,942.013,046.115,396.015,509.717,804.8
└ Inventories10,513.19,956.49,868.39,935.710,243.310,442.211,492.912,592.4
Total equity59,315.563,196.967,106.069,379.772,486.078,126.683,879.789,563.7
└ Attributable to owners55,995.459,825.663,666.869,114.972,218.077,819.783,570.189,279.9
└ Non-controlling interest3,320.13,371.23,439.2264.8267.9306.9309.7283.9
└ Share capital239.9239.9239.9239.9239.9239.9239.9239.9
Borrowings6,197.91,487.92,845.72,081.11,869.64,685.94,081.62,693.5
└ Current6,197.91,487.92,844.42,079.81,867.14,683.54,050.42,626.8
└ Non-current0.00.01.31.32.52.431.366.7
Trade payables5,681.55,699.55,653.35,732.56,184.36,705.67,333.87,419.0
Current liabilities19,906.415,022.616,983.817,254.618,194.223,415.322,622.023,591.6
Total liabilities21,428.116,244.318,356.918,736.019,614.625,579.924,905.525,274.7
Net debt(8,945.0)(13,345.4)(16,259.5)(18,041.1)(23,118.1)(23,194.5)(28,454.9)(30,876.6)
Debt / equity0.100.020.040.030.030.060.050.03
Current ratio2.002.622.562.672.892.572.822.94

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow4,959.35,718.712,135.06,299.214,072.14,781.012,419.23,141.3
└ Capex(2,085.6)(957.7)(2,201.8)(697.5)(2,128.6)(2,388.4)(3,609.4)(1,785.1)
Free cash flow2,873.84,760.99,933.25,601.711,943.52,392.68,809.81,356.2
Investing cash flow(7,943.7)993.7(690.2)(2,584.0)(5,306.2)(6,690.7)(11,344.1)8,306.6
Financing cash flow2,376.1(5,876.8)(6,710.2)(5,058.1)(7,905.8)1,100.8(2,512.6)(2,937.3)
└ Dividends paid(2,519.7)(961.2)(2,900.7)(1,201.1)(3,617.3)(1,320.0)(3,937.8)(1,199.7)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(608.3)835.64,661.9(1,342.9)860.1(808.8)(1,437.4)8,630.4

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SUNPHARMA at a glance

  • SUNPHARMA closed at ₹1,884.9 on 20 Nov 2026, -0.79% on the day, +7.3% over one year, 7.9% below its 52-week high of ₹2,046.9.
  • Delivery was 57.5% of traded quantity on 20 Nov 2026, the 54th percentile of its own 3,629 sessions with a reading (20-session average 56.1%, 1-year average 63.7%).
  • Market capitalisation is ₹4.52 lakh crore at a trailing P/E of 41.2 (trailing EPS ₹45.7).
  • Q2 FY27 results (consolidated, filed 30 Oct 2026): revenue ₹16,199 crore (+11.9% year on year), net profit ₹1,995 crore (-36.2%); the price moved -0.4% on the first session after.
  • Promoters held 52.68% at 30 Sept 2026, down 1.80 percentage points on the previous filing, with 0.01% of promoter shares pledged.
  • Q3 FY27 results are expected between 31 Jan 2027 and 31 Jan 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE044A01036
SeriesEQ
Listed8 Feb 1995
Former namesSun Pharmaceuticals Industries Limited (until 31 Mar 2017)
NSE market cap · 17 Nov 2026₹4.49L Cr
Free-float market cap (NSE)₹1.97L Cr
Shares outstanding (NSE)239.93Cr
History from9 Feb 1995
Sessions7,852
Turnover rank#45

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.